Switching from Reference to Biosimilars Does Not Reduce Efficacy and Safety in Juvenile Idiopathic Arthritis

被引：0
|
作者：
Maccora, Ilaria [1 ]
Simonini, Gabriele [2 ,3 ]
Bettiol, Alessandra [4 ]
Pagnini, Ilaria [5 ,6 ]
Lombardi, Niccolo [4 ]
Maniscalco, Valerio [5 ,6 ]
Crescioli, Giada [4 ]
Marrani, Edoardo [7 ]
Bonaiuti, Roberto [4 ]
Mastrolia, Maria Vincenza [2 ]
Ravaldi, Claudia [8 ]
Vannacci, Alfredo [4 ]
机构：
[1] Anna Meyer Childrens Univ Hosp, Paediat Rheumatol Unit, Sch Human Hlth Sci, Florence, Italy
[2] Meyer Childrens Univ Hosp, Rheumatol Unit, Florence, Italy
[3] Univ Florence, NEUROFARBA Dept, Florence, Italy
[4] Univ Florence, Sect Pharmacol & Toxicol, Dept Neurosci Psychol Drug Res & Child Hlth 2, Florence, Italy
[5] Anna Meyer Childrens Hosp, Rheumatol Unit 1, Florence, Italy
[6] Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth, Paediat Sect, Florence, Italy
[7] Univ Florence, Florence, Italy
[8] Univ Florence, Dept Hlth Sci 3, Florence, Italy
来源：
ARTHRITIS & RHEUMATOLOGY | 2020年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0712
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Efficacy and safety of rituximab in patients with juvenile idiopathic arthritis
    Alexeyeva, E. I.
    Bzarova, T. M.
    Valiyeva, S. I.
    Isayeva, K. B.
    Chomakhidze, A. M.
    Akulova, S. S.
    Amital, H.
    Lisitsyn, A. O.
    Denisova, R. V.
    Gudkova, E. Y.
    ACTA PAEDIATRICA, 2008, 97 : 69 - 70
  • [2] EFFICACY AND SAFETY OF ADALIMUMAB IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS
    Schmeling, H.
    Horneff, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 71 - 71
  • [3] The necessity, efficacy and safety of biologics in juvenile idiopathic arthritis
    Cakan, Mustafa
    Ayaz, Nuray Aktay
    Karadag, Serife Gul
    Tanatar, Ayse
    NORTHERN CLINICS OF ISTANBUL, 2020, 7 (02) : 118 - 123
  • [4] Efficacy and safety of Etanercept therapy in juvenile idiopathic arthritis
    Arina Lazareva
    Valda Stanevicha
    Jelizaveta Semjonova
    Ruta Shantere
    Inita Buliņa
    Pediatric Rheumatology, 9 (Suppl 1)
  • [5] EFFICACY AND SAFETY OF INFLIXIMAB IN JUVENILE IDIOPATHIC ARTHRITIS AND JUVENILE ANKYLOSING SPONDYLITIS
    Zeng, H.
    Zeng, P.
    Tang, Y.
    Wang, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 239 - 239
  • [6] Safety and efficacy of switching to biosimilars in IBD
    Isobel Leake
    Nature Reviews Gastroenterology & Hepatology, 2016, 13 (6) : 314 - 314
  • [7] The Efficacy, Safety, and Immunogenicity of Switching Between Reference Biopharmaceuticals and Biosimilars: A Systematic Review
    Barbier, Liese
    Ebbers, Hans C.
    Declerck, Paul
    Simoens, Steven
    Vulto, Arnold G.
    Huys, Isabelle
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 108 (04) : 734 - 755
  • [8] EFFICACY AND SAFETY OF SECUKINUMAB TREATMENT IN JUVENILE IDIOPATHIC ARTHRITIS PATIENTS
    Kriulin, I.
    Alexeeva, E.
    Dvoryakovskaya, T.
    Isaeva, K.
    Chomakhidze, A.
    Chistyakova, E.
    Lomakina, O.
    Denisova, R.
    Mamutova, A.
    Fetisova, A.
    Gautier, M.
    Vankova, D.
    Krekhova, E.
    Shingarova, M.
    Alshevskaya, A.
    Moskalev, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 485 - 485
  • [9] Efficacy and Safety of Methotrexate in Oligoarticular Persistent Juvenile Idiopathic Arthritis
    Schmeling, Heinrike
    Foeldvari, Ivan
    Horneff, Gerd
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S59 - S59
  • [10] Safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis
    Horneff G.
    Huppertz I.
    Haas P.
    Minden K.
    Ganser G.
    Hospach A.
    Trauzeddel R.
    Pediatric Rheumatology, 13 (Suppl 1)
12345